Sodium nitroprusside improves ischemia-induced neovascularization via the HO-1/NOX and AKT/eNOS signaling pathways in chronic kidney disease
- 8 December 2025
- journal article
- Published by Elsevier in Life Sciences
- Vol. 385, 124143
Abstract
No abstract availableKeywords
Funding Information
- Taipei Veterans General Hospital (V111D63-001-MY2)
- National Science and Technology Council (113-2314-B-A49-014)
- National Science and Technology Council (NSTC 114-2314-B-A49-075-MY3)
This publication has 60 references indexed in Scilit:
- Central and peripheral arterial diseases in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceKidney International, 2021
- AgeR deletion decreases soluble fms-like tyrosine kinase 1 production and improves post-ischemic angiogenesis in uremic miceAngiogenesis, 2020
- Hydralazine improves ischemia-induced neovasculogenesis via xanthine-oxidase inhibition in chronic renal insufficiencyPharmacological Research, 2020
- Treatment with sodium nitroprusside improves the endothelial function in aortic rings with endothelial dysfunctionEuropean Journal of Pharmaceutical Sciences, 2017
- Hypoxia inducible factor stabilization improves defective ischemia-induced angiogenesis in a rodent model of chronic kidney diseaseKidney International, 2017
- Indoxyl sulfate suppresses endothelial progenitor cell–mediated neovascularizationKidney International, 2016
- Amelioration of uremic toxin indoxyl sulfate-induced endothelial cell dysfunction by Klotho proteinToxicology Letters, 2012
- p-cresylsulfate and indoxyl sulfate level at different stages of chronic kidney diseaseJournal of Clinical Laboratory Analysis, 2011
- Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failureThe Lancet, 1992
- Central and regional hemodynamic effects of intravenous isosorbide dinitrate, nitroglycerin and nitroprusside in patients with congestive heart failureThe American Journal of Cardiology, 1981